Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Every year, the Working Group on Cardiovascular Pharmacotherapy organises a meeting named EuroCVP to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologistswith an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.
Indeed, all cardiologists are concerned by pharmacology and drugs therapy. Consequently, they should all participate and contribute to EuroCVP.
During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.
The ESC Working Group on Cardiovascular Pharmacotherapy presents an engaging and interactive course to improve the professional knowledge and skills on cardiovascular pharmacotherapy in older patients.
This two-day event will provide a deep insight into the long journey which brings pharmacological compounds from bench to bedside, i.e. from trial design for testing new drugs (generation of evidence and its critical appraisal) to implementation of pharmacological treatments for daily use in science and patient care.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.